Ann Hanham

Ann Hanham has been appointed the chair of HTG Molecular Diagnostics' board. Hanham has more than 15 years of experience in the life science investment sector as a founding member and managing partner of BAR Capital Management. Before that, she was a managing director and general partner of Burrill & Co.